CLINICAL_TRIALS
trial_result
· 2012-10-11
Clinical Trial Update: Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study [Phase 3]
Summary
Phase 3 immunogenicity study of Saizen for adult growth hormone deficiency was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Growth Hormone Deficiency (GHD) | Phase 3 | Status: TERMINATED | Results posted: 2012-10-11